,58 Thus, high MYCN expression in neuroblastomas harboring MYCN amplifications may explain increased footprints of ROS, replication slippage, and stress observed in mutational scenario #1, which was enriched in MYCN-amplified neuroblastomas. The gene discussed is MYCN; the disease is neuroblastoma.